SHR-1701, CAS 2891860-17-4

Product Description: SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Bo Cheng, et al. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond). 2022 Jan;42(1):17-36.

CAS Number: 2891860-17-4

Molecular Weight: N/A

Compound Purity: 99.77

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: PD-1/PD-L1;TGF-β Receptor

• SKU: MEXHY-P99944-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99944-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated